2021 - 2022 Elucidation of clinicopathological and molecular features of “tuft cell-like” breast cancer
Papers (77)：
Akane Higami, Masahiro Takada, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Kosuke Kawaguchi, Ayane Yamaguchi, Yasuhide Takeuchi, Yosuke Yamada, Masakazu Toi. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients. International Journal of Clinical Oncology. 2024
Hiroshi Oue, Eitaro Hiejima, Hideaki Okajima, Tatsuya Okamoto, Eri Ogawa, Elena Yukie Uebayashi, Etsuro Hatano, Takenori Suga, Yotaro Hanami, Kazushige Ashina, et al. Efficacy of steroid therapy for improving native liver survival after pediatric acute liver failure with immune activation. Hepatology Research. 2024
Yosuke Yamada, Stefan Küffer, Christian Sauer, Masahito Hoki, Shinsuke Shibuya, Hideaki Tsujii, Kazuo Ono, Koki Moriyoshi, Hiroshi Date, Akihiko Yoshizawa, et al. Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns. Virchows Archiv. 2024
Yosuke Yamada, Kai Mizoguchi, Eisuke Shiba, Honami Mishima, Shinya Otsuki, Masahito Hoki, Masahiro Hirata, Akio Sakamoto, Shuichi Matsuda, Alexander Marx, et al. A Case of Dedifferentiated Liposarcoma That Contributes to Accompanying Vessels of Various Size. Diagnostics. 2024. 14. 15. 1679-1679
Yoshinori Uchihara, Katsutsugu Umeda, Yosuke Yamada, Hiroaki Ito, Keiji Tasaka, Kiyotaka Isobe, Ryo Akazawa, Naoko Kawabata, Satoshi Saida, Itaru Kato, et al. MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma. Cancer Science. 2024
Yoshinori Uchihara, Katsutsugu Umeda, Keiji Tasaka, Takashi Mikami, Satoshi Saida, Itaru Kato, Hidefumi Hiramatsu, Yosuke Yamada, Nobuyuki Kakiuchi, Yukichi Tanaka, et al. Development of UESL via stepwise accumulation of C19MC miRNAs overexpression and TP53 aberration. The 83rd Annual Meeting of the Japanese Cancer Association. 2024
Yosuke Yamada, Yasuhiro Yamada. Cancer and aging studies with in vivo reprogramming technology. 2024
Alexander Marx, Philipp Ströbel, Yosuke Yamada. New Markers and Genomics of Thymic Epithelial Tumors. Pulmonary Pathology Society Biennial Meeting. 2024
Rie Ota, Masako Kataoka, Mami Iima, Maya Honda, Aika Okazawa, Mizue Suzuki, Shotaro Kanao, Takeshi Kubo, Yosuke Yamada, Yasuhide Takeuchi, et al. Predicting Disease-Free Survival By DWI And DCE MRI Scores For Breast Cancer Patients With Neoadjuvant Systemic Treatment. 2024 ISMRM & ISMRT Annual Meeting & Exhibition. 2024
Masako Kataoka, Aika Okazawa, Rie Ota, Maya Honda, Mami Iima, Yasuhide Takeuchi, Yosuke Yamada, Masahiro Kawashima, Masahiro Takada, Yuji Nakamoto. DCE and DWI based Parameters at Interim MRI as a tool for the Early Prediction of Neoadjuvant SystemicTherapy. 2024
Pathology and Clinical Medicine. The Thymus and Mediastinum: For every pathologist
2023
病理と臨床「病理診断クイックリファレンス2023」
文光堂 2023
腫瘍病理鑑別診断アトラス 縦隔腫瘍・胸膜腫瘍 第2版
文光堂 2022
外科病理診断学 : 原理とプラクティス
金芳堂 2018 ISBN:9784765317665
がん化学療法・分子標的治療update
中外医学社 2009 ISBN:9784498022447
Lectures and oral presentations (16)：
Optimizing Pathologic Biomarkers of Immunotherapy: The Road Forward
(2024 World Conference on Lung Cancer, ES39 - Biomarkers and Beyond 2024)
Molecular Pathology/Genetics of Thymic Tumors
(13th International Thymic Malignancy Interest Group Annual Meeting 2023)
Whether tuft cells are present in the human breast?: the potential relevance to triple-negative breast cancer
(Tuft Cells 2023 (Von Behring-Röntgen and Leopoldina-Symposium Tuft Cells) 2023)
2008 - 2011 Hokkaido University Graduate School of Medicine
1999 - 2005 Kanazawa University Graduate School of Medicine
Professional career (2)：
Ph.D. (Hokkaido University)
M.D. (Kanazawa University)
Work history (12)：
2024/02 - 現在 The University of Tokyo Department of Molecular Pathology, Graduate School of Medicine Associate Professor
2020/06 - 2024/01 Kyoto University Department of Diagnostic Pathology, Kyoto University Hospital Senior Lecturer
2023/08 - 2023/08 University Medical Center Göttingen, University of Göttingen Institute of Pathology Guest scientist
2019/08 - 2020/05 Kyoto University Department of Diagnostic Pathology, Kyoto University Hospital Assistant professor
2018/04 - 2019/07 Heidelberg University Institute of Pathology, Medical Faculty Mannheim Guest scientist and Scientific employee
2013/04 - 2018/03 Kyoto University Department of Diagnostic Pathology, Kyoto University Hospital Assistant professor
2012/10 - 2016/03 Kyoto University Department of Reprogramming Science Researcher
2012/10 - 2013/03 Kyoto University Department of Diagnostic Pathology, Kyoto University Hospital Resident
2011/10 - 2012/09 Hokkaido Univerisity Hospital Department of Surgical Pathology Associate Professor
2007/04 - 2011/09 Hokkaido Univerisity Hospital Department of Surgical Pathology Resident
2006/04 - 2007/03 Hokkaido University Hospital Junior resident
2005/04 - 2006/03 Hokkaido University Hospital Junior resident
Show all
Committee career (6)：
2023/01 - 現在 The Japan Lung Cancer Society 病理委員会委員
2017/04 - 現在 The Japanese Society of Clinical Cytology 指導医
2015/05 - 現在 The Japanese Society of Pathology 学術評議員
2022/04 - 2024/03 The Japanese Society of Pathology, Kinki Division 学術委員
2020/04 - 2024/03 The Japanese Society of Pathology 病理専門医資格審査委員会/更新委員会委員
2021/07 - 2021/11 The Japan Lung Cancer Society 日本肺癌学会 アドホック胸部腫瘍改定作業小委員会委員
Show all
Awards (3)：
2023/12 - Mediastinum Outstanding Authors (2023) Pathological snapshots of thymic epithelial tumors with invasion into neighboring structures: preparing for the forthcoming revision of the TNM classification
2022/11 - The Japanese Society of Pathology The Case Research Award presentation at the Sixty-eighth Autumn Annual Meeting of the Japanese Society of Pathology Investigation of expression of cortical and medullary markers in thymic epithelial tumors
2014/08 - The Japanese Society of Pathology The Best Poster Award at 11th JSP Conference for Investigative Pathology Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation
Association Membership(s) (6)：
The Japan Lung Cancer Society
, The International Association for the Study of Lung Cancer (IASLC)
, The International Thymic Malignancy Interest Group (ITMIG)
, Japanese Assocition for Research on the Thymus
, The Japanese Society of Clinical Cytology
, The Japanese Society of Pathology
